Oncology News

The routine use of a molecular testing panel developed at UPMC greatly increases the likelihood of performing the correct initial surgery for patients with thyroid nodules and cancer , report researchers from the University of Pittsburgh Cancer Institute , partner with UPMC CancerCenter.

What wouldn't you do to save your K-9's life? For one valley pet owner, she says she will do anything.

Although cervical cancers are declining in the United States and Canada, other cancers linked to human papillomavirus are increasing, a new study indicates.

A new lump or change in your dog's behaviour could be a sign of cancer. Veterinary surgical oncologist, and author of "Lucky Dog," Sarah Boston gives tips on how to detect the disease.

The European Society for Medical Oncology , the leading pan-European association representing medical oncology professionals, has expressed concern that the proposed EU General Data Protection Regulation [1] could make cancer research impossible and add a significant burden to both doctors and cancer patients.

Joel Helmke is the new corporate vice president of oncology services at WellStar's cancer center, reports Marietta Daily Journal.

Kinex Pharmaceuticals announced the receipt of an allowance by the US FDA for the Company's KX2-391 Ointment for the commencement of a Phase I clinical study in actinic keratosis.

Kate Smith, a resident at The Meadows assisted-living apartments in Elk Grove, meets Humiko, a Shiba Inu and Lend-A-Heart volunteer while accompanied by her owner Jody Bryan, right, on Monday evening, July 14, 2014.

A new study has provided hope that previously studied SapC-DOPS could be used for treatment of brain cancer that has spread.

Fans of Houston doctor Stanislaw Burzynski love him for defying the medical establishment and offering alternative therapies to terminally ill patients.

A Boston biotech working in partnership with synthetic biology company Intrexon Corp. is developing cancer drugs that can be turned on and off using a pill.

Agenus Inc. , an immuno-oncology company developing a portfolio of checkpoint modulators , heat shock protein peptide-based vaccines, and adjuvants, today announced its financial results and business highlights for the second quarter ended June 30, 2014.

Bristol-Myers Squibb Co.' s exit from the diabetes business, plus higher taxes and research spending, combined to slash the drugmaker's second-quarter profit by 38 percent, but the company handily beat Wall Street's muted profit expectations.

Potential treatments for melanoma and other cancers will take shape in a laboratory at University of South Florida Research Park.

The U.S. Food and Drug Administration today approved Zydelig to treat patients with three types of blood cancers.

During National Cancer Survivors month June 2014, I had the pleasure of visiting The Breast Center at University of Maryland St. Joseph Medical Center.

You know how people toss around the phrase "the cure is worse than the disease"? They should meet Jim Olson.

Hayley Cook/WDNAmy Morgan, oncology patient navigator at the Appalachian Regional Hospital Regional Medical Center in Hazard, Kentucky demonstrates how the Skin Scope screening device is used.

The Children's Hospital of San Antonio has taken another step in its quest to develop a world-class pediatric cancer program.

During daylight hours, Dr David Robert Grimes takes on the serious and important job of battling cancer.